CTOs on the Move

Tobii Dynavox

www.tobiidynavox.com

 
Tobii Dynavox, a wholly owned subsidiary of Tobii AB (publ), is the leading global provider of eye tracking enabled and touch-based augmented and alternative communication (AAC) devices as well as symbol-based products for individuals with special needs.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

American Endoscopy Services Inc

American Endoscopy Services Inc is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bard Electrophysiology

Bard Electrophysiology is a Lowell, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GNYHA Ventures

GNYHA Ventures is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Southwest Technologies

Southwest Technologies, Inc. offers healthcare providers information and resources in this section of our site. Journal Articles is a listing of professional articles which contain pertinent information regarding our products. Case Studies contains

Contego Medical

Contego Medical, founded in 2005, has developed a family of novel emboli protection devices. The main feature of each device is that the treatment portion (i.e., balloon or stent) is on the same catheter as the embolic protection device, thus coupling the two together. This device can act as an angioplasty balloon with an integrated emboli protection device. If a stent is mounted on the balloon, it can serve as a stent with an integrated emboli protection device. We know that embolization occurs with all angioplasty and stenting procedures. It is usually hard to predict which ones will result in clinical sequalae. Despite knowing that embolization is ubiquitous, embolic protection devices are not used in all procedures as they add complexity, time, and cost. Dedicated devices do not exist for renal intervention, although the majority of physicians say they would use one if it existed. Contego Medical’s family of embolic protection devices represent a paradigm shift in the treatment of cardiovascular disease.